- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03377166
Measuring Subjective Visual Vertical (SVV) Using a Smartphone Application
January 9, 2019 updated by: michal roll, Tel-Aviv Sourasky Medical Center
A comparison between two methods evaluating SVV: Bucket Test and A smartphone-based test.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel Aviv, Israel
- The Tel Aviv Sourasky Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Vestibular Disorder
Exclusion Criteria:
- Chronic ear disease, Neurological disorder, s/p Ear surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Vertigo
Participants with vestibular disorder
|
Bucket test and Smartphone-based evaluation of SVV
|
|
Active Comparator: Control
Participants without vestibular disorder
|
Bucket test and Smartphone-based evaluation of SVV
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Results of Bucket test Smartphone-based evaluation of SVV
Time Frame: 5 minutes
|
5 minutes
|
|
Results of Smartphone-based evaluation of SVV
Time Frame: 5 minutes
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Actual)
December 19, 2018
Study Completion (Actual)
December 19, 2018
Study Registration Dates
First Submitted
December 7, 2017
First Submitted That Met QC Criteria
December 13, 2017
First Posted (Actual)
December 19, 2017
Study Record Updates
Last Update Posted (Actual)
January 11, 2019
Last Update Submitted That Met QC Criteria
January 9, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 0113-17-TLV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.